Publications by authors named "David S Mathai"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

203

Total Likes

329

Extended Reach

331,586

Social Features

115
N
Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.
Sandeep M Nayak, Hillary Jackson, Nathan D Sepeda, David S Mathai, Sara So, Abigail Yaffe, Hadi Zaki, Trey J Brasher, Matthew X Lowe, Del R P Jolly

Front Psychiatry· September 2023

Videos about Article: user user user

3 1 10 109 2 4

View All Article and Social Media Activity
R
Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.
David S Mathai, Jill O Robinson, Kevin Wagner, Logan Neitzke-Spruill, Dayan Berrones

Braz J Psychiatry· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use.
David S Mathai, Daniel E Roberts, Sandeep M Nayak, Nathan D Sepeda, Amy Lehrner

J Psychoactive Drugs· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On Minimizing Risk and Harm in the Use of Psychedelics.
Jules Evans, Marc Aixalà, Brian T Anderson, William Brennan, Rebecka Bremler, David S Mathai

Psychiatr Res Clin Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning how to make use of dissociative therapies.
David S Mathai

Int Rev Psychiatry· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.
Erin Wang, David S Mathai, Natalie Gukasyan, Sandeep Nayak, Albert Garcia-Romeu

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data.
David S Mathai, Thomas D Hull, Leonardo Vando, Matteo Malgaroli

J Affect Disord· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.
David S Mathai, Samantha Hilbert, Nathan D Sepeda, Justin C Strickland, Roland R Griffiths

Psychedelic Med (New Rochelle)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamine.
David S Mathai, Sandeep M Nayak, David B Yaden, Albert Garcia-Romeu

Psychopharmacology (Berl)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping consent practices for outpatient psychiatric use of ketamine.
David S Mathai, Scott M Lee, Victoria Mora, Kelley C O'Donnell, Albert Garcia-Romeu

J Affect Disord· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The conundrum of therapeutic intoxication.
David S Mathai, David B Yaden, Kelley C O'Donnell

Br J Psychiatry· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward Synergies of Ketamine and Psychotherapy.
David S Mathai, Victoria Mora, Albert Garcia-Romeu

Front Psychol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep transcranial magnetic stimulation for obsessive compulsive disorder.
Alexis G McCathern, David S Mathai, Raymond Y Cho, Wayne K Goodman, Eric A Storch

Expert Rev Neurother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review.
David S Mathai, Matthew J Meyer, Eric A Storch, Thomas R Kosten

J Affect Disord· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys.
Christopher D Verrico, David S Mathai, Hong Gu, Allan R Sampson, David A Lewis

J Psychopharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Guanfacine for Cannabis Use Disorder and Related Symptomology.
Manuela Holst, David S Mathai, Marguerite M Patel, Christopher Rodgman, Jake Keller

Am J Addict· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study.
David S Mathai, Manuela Holst, Christopher Rodgman, Colin N Haile, Jake Keller

J Neuropsychiatry Clin Neurosci· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents.
David S Mathai, Christopher D Verrico, Daryl Shorter, John H Coverdale, Thomas R Kosten

Am J Addict· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis